ArticleDrug, healthcare and patient safety2010

Phosphodiesterase-5 inhibitors in management of pulmonary hypertension: safety, tolerability, and efficacy.

Mitchell S Buckley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.